XML 52 R41.htm IDEA: XBRL DOCUMENT
v3.8.0.1

5) Stock-based Compensation: Schedule of stock inventive plan changes (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Tables/Schedules |
Schedule of stock inventive plan changes |
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at December 31, 2017 |  | 880,426 |  | $ 4.35 |  | 523,603 |  | $ 5.24
Granted |  | - |  |  |  | - |  |
Exercised |  | (31,984) |  |  |  | - |  |
Cancelled |  | (5,704) |  |  |  | - |  |
Outstanding at March 31, 2018 |  | 842,738 |  | $ 4.48 |  | 523,603 |  | $ 5.24
As of March 31, 2018: |  |  |  |  |  |  |  |
Options exercisable |  | 744,686 |  | $ 4.40 |  | 468,477 |  | $ 5.29
As of March 31, 2018: |  |  |  |  |  |  |  |
Available options for future grant |  | 421,241 |  |  |  | 165,638 |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
outstanding at March 31, 2018 |  | 6.55 years |  |  |  | 3.19 years |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
exercisable at March 31, 2018 |  | 6.53 years |  |  |  | 2.43 years |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
outstanding at March 31, 2018 (1) |  | $850,528 |  |  |  | $251,961 |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
exercisable at March 31, 2018 (1) |  | $836,882 |  |  |  | $232,667 |  |
(1) The Company used a stock price of $5.15 as of March 31, 2018 to derive intrinsic value.
A summary of the status of the Company’s stock compensation plans as of March 31, 2017, and the changes during the three months ended March 31, 2017, are presented below:
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at December 31, 2016 |  | 741,973 |  | $ 4.33 |  | 556,298 |  | $ 4.61
Granted |  | - |  |  |  | - |  |
Exercised |  | - |  |  |  | - |  |
Cancelled |  | - |  |  |  | - |  |
Outstanding at March 31, 2017 |  | 741,973 |  | $ 4.33 |  | 556,298 |  | $ 4.61
As of March 31, 2017: |  |  |  |  |  |  |  |
Options exercisable |  | 636,764 |  | $ 3.94 |  | 493,298 |  | $ 4.26
As of March 31, 2017: |  |  |  |  |  |  |  |
Available options for future grant |  | 253,432 |  |  |  | - |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
outstanding at March 31, 2017 |  | 7.12 years |  |  |  | 2.42 years |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
exercisable at March 31, 2017 |  | 6.70 years |  |  |  | 2.13 years |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
outstanding at March 31, 2017 (1) |  | $1,837,828 |  |  |  | $1,264,540 |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
exercisable at March 31, 2017 (1) |  | $1,824,086 |  |  |  | $1,264,540 |  |
(1) The Company used a stock price of $6.80 as of March 31, 2017 to derive intrinsic value.

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlockSupplementAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration